EncrypGen is harnessing blockchain technology to return the ownership of genomic data to individuals and to empower you to control who and what gets access to your data no matter who provides your tests.
Blockchain technology is quickly becoming the gold standard ledger and database tool in practically every corner of the global industry. It’s being applied to things like cloud storage, manufacturing, education and more. EncrypGen, however, is the first company to take this technology and use it in genomics.
Read the full article at globalcoinreport.com